.4 mm Hg increase from basal), which declined gradually to a steady state pressure of 13-3-15*1 mm Hg (4-0-5.0 mm Hg increase). There was no significant difference between pressure increases produced by microspheres of differing sizes. It is concluded that portal hypertension can be produced acutely by blocking portal radicles with microspheres. The maximum pressure achieved, however, is substantially less than that obtained by total portal vein occlusion (mean: 57 6 mm Hg). This suggests the existence of functional intrahepatic portal systemic shunts not previously described in the normal liver.
The management of portal hypertension (PHT) has for long periods rested almost exclusively on the reduction in flow in variceal vessels, either surgically or endoscopically. Recently, however, it has become apparent that PHT is more a systemic disorder with, in particular, a hyperdynamic splanchnic circulation.' Efforts have therefore been directed at the pharmacological manipulation of the gastrointestinal and hepatic circulations to reduce splanchnic and extrahepatic variceal flow2 while maintaining or even increasing hepatic portal inflow through the use of intrahepatic portal vasodilators. 3 Research into pharmacological or surgical manipulation of by the lack of a reliable, reproducible, and clinically comparable animal model of PHT. Prehepatic portal occlusion and cirrhotogens have been used, but their use has been limited, in the first by the rapid development of portoportal collaterals, which decompress the portal occlusion, and in the second by the variability of the liver damage induced. They thus both fail to fulfil the above criteria and, in particular, do not permit the study of subtle changes in the intra and extrahepatic portal circulation. There are two strands of evidence to suggest that microspheres could be utilised to create an alternative model of PHT, by occluding intrahepatic portal radicles. Firstly, it has been shown that over 95% of intraportally infused 15 [tm microspheres lodge in the normal liver. ' Secondly, exogenously applied pancreatic cells, when injected intraportally, have been shown to produce PHT.7 It therefore seemed possible that microspheres could be used to occlude the intrahepatic portal tract, thus creating a model of PHT that could be rapidly and reliably established, and would be fairly comparable with the clinical situation. Furthermore, in contrast with prehepatic portal occlusion models, the intrahepatic nature of this block would seem to preclude the formation of decompressing portoportal collaterals.
The aims of this acute experimental study were: (1) to confirm that microspheres given intraportally would produce an increase in portal pressure; (2) (Fig 1) . When steady resting pressures had been achieved for at least five minutes, 10 sequential aliquots of microspheres of varying diameters (see Table I ) were manually injected through the portal cannula over a 20 minute period, each injection taking [10] [11] [12] [13] [14] [15] applied to the portal vein at the liver hilum and pressure monitored (Fig 1) . Animals were then rapidly killed with high dose intra-arterial barbiturate. Finally the liver, spleen, and lungs were removed for histological examination.
Statistics -statistical comparisons within and between groups were made using Student's paired and unpaired t tests respectively, with p<0 05 being regarded as statistically significant. Data are shown as mean (SEM).
Results
After two to five sequential injections, microsphere aliquots had begun to produce an increase in portal pressure to a peak that gradually declined to a new steady state within 30-60 seconds. Each subsequent aliquot raised the peak and steady state pressure further until a maximum was reached (after six to eight aliquots) ( Fig  2) . Once this maximum pressure was attained, no further pressure rise could be achieved even after further injections of large numbers of microspheres. No effect on arterial blood pressure was seen. Equivalent saline aliquots had no effect on portal or systemic pressures. Table II lists the basal, peak, and steady state pressures achieved after sequential injections of microspheres of increasing diameter. Each microsphere size produced a statistically significant increase in portal pressure from basal to peak (8-7-12 4 mm Hg increase) and basal to steady state (4 0-5 0 mm Hg increase) (Table II) . There were no statistically significant differences between pressure increases produced by microspheres of different diameters. Splenic pulp pressures, though usually damped, closely paralleled those measured directly in the portal vein (Table II) .
Hilar portal vein occlusion produced a dramatic rise in portal pressure from the new steady state to 57 6 (1I2) mm Hg (Fig 3) . Release of the occlusion was followed by a return to the previous hypertensive resting state. Histological examination of sections of the liver showed the presence of large numbers of microspheres. In particular, 15 ,um spheres were seen in the smallest portal radicles (Fig 4A) , while 90 ,tm spheres lodged in larger portal radicles (Fig 4B) .
No microspheres were seen in the spleen, but many spheres of all diameters were noted in the lungs (Fig 4C) . bed is reached and therefore smaller numbers produce an effect similar to that induced by a greater number of smaller spheres, which lodge most distally. Confirmation was achieved histologically, where 90 [im microspheres were seen trapped in large portal radicles. By contrast, 15 pim spheres were seen principally within the finest and most distal portal radicles.
The higher 'peak' pressures in comparison with the steady state pressure is probably an acute 'volume' effect. Even a volume of 0.2 ml injected slowly into a portal vein that is partially obstructed has an effect, which is seen most obviously in the portal vein cannula recording and to a lesser extent in the splenic pulp. As the portal flow through the liver becomes progressively obstructed, the effect becomes more obvious -with peak pressures being 4-7 mm Hg higher than the subsequent steady state measurement. In fact, small volume saline injections given at this stage (that is, after microspheres), produced small but significant pressure increases *'|~and therefore this model of PHT, once estab-40 lished, seems to have a reduced portal tract 'capacitance'. As noted above, control intraportal saline injections given before micro-spheres have no effect on portal or splenic pressure.
Although the final portal pressure (13-3-15-1 mm Hg) produced acutely by microspheres compares favourably with the other portal hypertension models (and also a recent report from Japan'3 using larger microspheres in rabbits), it is intriguing that much higher pressures are not attainable. In previous work in our laboratory, where the extrahepatic portal tract was totally occluded (by a clamp applied across the portal vein at the liver hilum), portal pressure reached a mean of 56-0 mm Hg,'4 and in the present study an almost identical pressure was found. Assuming an even distribution of spheres, it should be possible progressively to occlude all the intrahepatic radicles, at which stage the pressure should approximate to that achieved by total portal occlusion. The ' open' rapidly in response to a raised portal pressure, and permit shunting of blood directly into the hepatic veins. This would explain why increasing numbers of microspheres have no further pressure raising effect, why microspheres can be found in large numbers in the pulmonary bed and why, when these intrahepatic shunts are excluded by prehepatic clamping, the portal pressure rises to a value usually only seen in the total absence of any collaterals.
One ofthe significant advantages of this microsphere model is that portal hypertension is induced acutely while sparing the normal liver architecture. We believe that this model is reliable, reproducible, and clinically more relevant than prehepatic occlusion models. We intend to extend our measurements to a longer term study after microsphere injection, and to use this model to study pharmacological control of the hypertensive portal tract and to confirm the existence of intrahepatic portal systemic shunts in the normal rat liver. 
